NCT02135679View on ClinicalTrials.gov

The Detection Of Circulating Tumor Cells (CTC) In Patients With NSCLC Undergoing Definitive Radiotherapy Or Chemoradiotherapy

CompletedOBSERVATIONAL
Enrollment

204

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2021

Conditions
Non-small Cell Lung Cancer
Interventions
RADIATION

Radiotherapy

Trial Locations (1)

19104

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

Abramson Cancer Center at Penn Medicine

OTHER

NCT02135679 - The Detection Of Circulating Tumor Cells (CTC) In Patients With NSCLC Undergoing Definitive Radiotherapy Or Chemoradiotherapy | Biotech Hunter | Biotech Hunter